SynthesisFrontiers in oncology2026
Correlation between serum triglycerides and prostate cancer risk in Chinese men: a meta-analysis.
Synthesis in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Epidemiological research presents inconsistent findings on the association between serum triglyceride levels and the risk of developing prostate cancer. However, a systematic review and meta-analysis study on the relationship between triglyceride levels and the risk of prostate cancer in Chinese men are limited. Methods: We explored PubMed, Wanfang, and the China National Knowledge Infrastructure (CNKI) databases to find related retrospective studies on the link between serum triglycerides and prostate cancer. The Newcastle-Ottawa Scale was employed to assess the quality of the study. To compute the pooled odds ratios (OR), a random effects model was utilized. Results: Twelve studies were included, comprising 4732 cases. For prostate cancer, the OR for serum triglyceride levels were 1.03 (95%CI:0.755-1.404, P=0.898). Furthermore, subgroup analysis indicated no link between serum triglyceride levels and prostate cancer risk. Conclusion: We observed no relationship between serum triglyceride and the likelihood of prostate cancer in Chinese men. Due to wide confidence intervals, these results require cautious interpretation and confirmatory replication.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.